Lundbeck VP joins board of migraine firm

Rehaler, which is developing a medical device to treat migraine episodes, has expanded its board with the addition of Bjørn Krogh Sperling, who is also spearheading Lundbeck’s migraine and pain research.
Photo: Rehaler / PR
Photo: Rehaler / PR
by albert rønning-andersson, translated by daniel pedersen

Rehaler, a migraine firm developing a medical device of the same name to treat migraine episodes, has expanded its board of directors with a Lundbeck leader, Bjørn Krogh Sperling, according to a filing on the Danish Central Business Register.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading